Kcl B. Braun (Potassium Chloride)

• Kcl B. Braun is used to address disorders of potassium balance and related electrolyte disturbances.
• Hypokalemia: restores normal serum potassium levels in patients with low potassium.
• Potassium supplementation: provides essential potassium ions during peri‑operative or critical‑care management.
• Electrolyte imbalance: corrects overall electrolyte disturbances when potassium is deficient.

• Potassium Chloride dissociates after intravenous administration, releasing potassium ions that enter extracellular fluid. The increased extracellular potassium drives diffusion into cells, re‑establishing the normal transmembrane gradient and supporting cellular electrical activity, muscle contraction, and nerve conduction. This helps normalize serum potassium concentrations and restores physiological functions dependent on adequate potassium levels.

Adverse reactions may occur with intravenous potassium chloride administration.

Common Side Effects

• Pain or irritation at the injection site
• Phlebitis or vein inflammation
• Nausea or mild gastrointestinal discomfort
• Transient hypotension during rapid infusion
• Mild muscle weakness

Serious or Rare Side Effects

• Hyperkalemia leading to cardiac arrhythmias
• Severe bradycardia or cardiac arrest
• Anaphylactoid reactions
• Tissue necrosis if extravasation occurs
• Severe electrolyte disturbances such as metabolic acidosis

• When using Kcl B. Braun, clinicians should observe several safety measures.
• Monitor serum potassium: check levels before and during infusion.
• Use infusion pump: control rate to avoid rapid administration.
• Avoid rapid bolus: limit infusion to recommended maximum rates.
• Assess renal function: adjust dose in impaired clearance.
• Contraindicated in hyperkalemia: do not administer when serum potassium is already elevated.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid)

• ACE inhibitors: may cause additive hyperkalemia.
• Angiotensin II receptor blockers: increase risk of elevated potassium.
• Potassium‑sparing diuretics (e.g., spironolactone): potentiate hyperkalemia.
• NSAIDs: reduce renal potassium excretion, raising serum levels.
• Trimethoprim‑sulfamethoxazole: can raise potassium concentrations.

Moderate Interactions (Monitor Closely)

• Digoxin: hyperkalemia may enhance digoxin toxicity.
• Beta‑blockers: monitor cardiac rhythm if potassium rises.
• Insulin: may mask hypokalemia symptoms.
• Corticosteroids: can affect potassium distribution.
• Lithium: concurrent use may alter lithium clearance.